Trials / Completed
CompletedNCT01598116
A Prospective Longitudinal Study to Identify Biomarkers in Children With Hemangiomas
A Prospective Longitudinal Study to Identify Biomarkers in Children With Hemangiomas.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 68 (actual)
- Sponsor
- Gayle Gordillo · Academic / Other
- Sex
- All
- Age
- 4 Weeks – 5 Months
- Healthy volunteers
- Accepted
Summary
Current treatment options for hemangiomas, such as propranolol, steroids and interferon, all have the potential for significantly harmful side effects. The purpose of this study is to identify potential biomarkers that can be used to design clinical trials and accelerate the delivery of new treatment alternatives to children with hemangiomas.
Detailed description
Urine will be collected from children with hemangiomas and age-matched healthy controls at 2,4,6,9,12,18 and 24 months of age. Children with hemangiomas will also have ultrasound examination performed at each visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Urine collection and ultrasonography | Bagged urine collection and ultrasound at each visit |
| PROCEDURE | Urine collection | Bagged urine collection |
Timeline
- Start date
- 2010-12-12
- Primary completion
- 2015-12-15
- Completion
- 2017-01-10
- First posted
- 2012-05-15
- Last updated
- 2021-12-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01598116. Inclusion in this directory is not an endorsement.